Hong Kong as a platform for Eyebright Medical’s international outreach

Eyebright Medical Technology (Beijing) Co., Ltd. (“Eyebright Medical”, the “Company”, Stock Code: 688050.SH) signed an MOU with Invest Hong Kong (InvestHK), during the 27th Beijing-Hong Kong Economic Cooperation Forum & Investment Promotion Conference, on September 20 (2024), leveraging Hong Kong as a base for its international expansion.

Invest Hong Kong (Hong Kong SAR Government organisation) will provide essential information on the business environment and government policies,along with a suite of support services, including talent acquisition, financing options, and government funding programs.

ESCRS 2024 & Showcasing the Leading R&D Capabilities to the World

At the recent ( September 6-10) 42^nd European Society of Cataract and Refractive Surgeons Congress (ESCRS), Eyebright Medical showcased its range of self-developed products in cataract surgery, myopia management, and consumer vision care, receiving significant recognition in the global market & reinforcing its commitment to excellence in ophthalmic care. The event attracted over 15,000 participants facilitating valuable exchanges among leading ophthalmic experts.

Products

Eyebright Medical’s star products, such as the monofocal EDOF intraocular lens, multifocal EDOF intraocular lens, & preloaded high-order aspheric intraocular lens series, attracted delegates from around the world, eager to learn about & experience these cutting-edge innovations.Multifocal EDOF lenses enhance postoperative intermediate & near vision, while monofocal EDOF lenses reduce adverse visual phenomena while improving distance & near vision. The preloaded intraocular lens features a streamlined one-step operation design that greatly improves surgical efficiency & safety. Eyebright Medical’s high-end intraocular lens series effectively meets the needs of refractive cataract surgery patients with corresponding toric versions.

The company has strategically expanded its product pipeline to cover the full life cycle of eye health solutions, anchored by its three core product categories – intraocular lenses, orthokeratology lenses, & soft contact lenses. China’s ‘intelligent manufacturing’ power is propelling Eyebright Medical towards becoming the world’s leading medical enterprise.

With this new agreement and support from InvestHK Eyebright Medical’s internationalisation strategy is ready to go.